Earlier, we showed that the main mediators of heterosubtypic cross‐protection induced in mice by SC administration of WIV are flu‐specific CD8+ T cells.9 Therefore, we evaluated the impact of different vaccine administration routes on the magnitude of the induced flu‐specific CD8+ T‐cell response. The gene discussed is CD8A; the disease is influenza.